(Q40874734)

24 September 2017

title

Strengths and limitations of meta-analysis: larger studies may be more reliable (English)

1 reference

24 September 2017

Flather MD

1

1 reference

24 September 2017

Farkouh ME

series ordinal

2

1 reference

24 September 2017

Pogue JM

series ordinal

3

1 reference

24 September 2017

Yusuf S

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

Contemporary Clinical Trials

24 September 2017

published in

1 reference

24 September 2017

volume

18

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

568-79; discussion 661-6

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Why do we need some large, simple randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Obtaining medically meaningful answers from an overview of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Why do we need systematic overviews of randomized trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Lessons from overviews of cardiovascular trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Can meta-analyses be trusted?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Problems induced by meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Invited commentary: a critical look at some popular meta-analytic methods

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Confronting publication bias: a cohort design for meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Publication bias and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Publication bias in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Estimation issues in clinical trials and overviews

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Methods for combining randomized clinical trials: strengths and limitations.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Inter-study differences: how should they influence the interpretation and analysis of results?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

A comparison of statistical methods for combining event rates from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Meta-analysis and evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Approaches to sample size estimation in the design of clinical trials--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Mega-trials and management of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Magnesium in acute MI. Timing is critical

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Magnesium in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Toward prospective registration of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

Meta-analysis: reconciling the results of independent studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900024-X

7 January 2021

10.1016/S0197-2456(97)00024-X

Identifiers

DOI

1 reference

24 September 2017

1 reference